MRNA
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)Moderna, Inc. - Common Stock (MRNA) [ST]
www.modernatx.com ↗▲ 6.99%
prev close
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 25 mRNA development candidates in clinical studies as of March 2026. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
Congressional Trades
6
All tracked trades
Members Trading
4
Unique members
Net Activity
-4
1 buys · 5 sells
Members Who Traded This Stock
6 trade events
| Date | Member | Stock | Type | Amount | Filed | Signal |
|---|---|---|---|---|---|---|
| 2026-09-24 | MRNAModerna, Inc. - Common Stock | Sell | $1,001 - $15,000 | 13d ago | — | |
| 2026-08-19 | MRNAModerna, Inc. - Common Stock | Sell | $1,001 - $15,000 | 41d ago | — | |
| 2026-08-19 | MRNAModerna, Inc. - Common Stock | Buy | $1,001 - $15,000 | 41d ago | — | |
| 2025-04-08 | MRNAModerna, Inc. - Common Stock | Sell | $1,001 - $15,000 | 530d ago | — | |
| 2025-01-15 | MRNAModerna, Inc. - Common Stock | Sell | $1,001 - $15,000 | 615d ago | — | |
| 2024-02-01 | MRNAModerna, Inc. - Common Stock | Sell | $1,001 - $15,000 | 957d ago | — |
2026-09-24
Maria Elvira Salazar
MRNA
Amount
$1,001 - $15,000
Filed
13d ago
2026-08-19
Maria Elvira Salazar
MRNA
Amount
$1,001 - $15,000
Filed
41d ago
2026-08-19
Maria Elvira Salazar
MRNA
Amount
$1,001 - $15,000
Filed
41d ago
2025-04-08
Rob Bresnahan
MRNA
Amount
$1,001 - $15,000
Filed
530d ago
2025-01-15
Julie Johnson
MRNA
Amount
$1,001 - $15,000
Filed
615d ago
2024-02-01
Josh Gottheimer
MRNA
Amount
$1,001 - $15,000
Filed
957d ago
Recent News
Powered by Polygon.io
Another BioNTech Cancer Vaccine Just Hit a Major Setback. Is BNTX Stock Still a Buy?
Moderna Just Joined the Nasdaq-100. Here's What That Means for Investors.
Sandisk Is Dominating the S&P 500 in 2026. Can It Repeat in 2027?
Move Aside, Moderna: This mRNA Stock Is Sitting on a Cash Pile and a Deep Cancer Pipeline
The Nasdaq-100's 6 Best Stocks This Year, and Whether They Can Keep Going
Trade Timeline
Congressional activity, newest first
Maria Elvira Salazar
2026-09-24 · Sale
$1,001 - $15,000
Maria Elvira Salazar
2026-08-19 · Sale
$1,001 - $15,000
Maria Elvira Salazar
2026-08-19 · Purchase
$1,001 - $15,000
Rob Bresnahan
2025-04-08 · Sale
$1,001 - $15,000
Julie Johnson
2025-01-15 · Sale
$1,001 - $15,000
Josh Gottheimer
2024-02-01 · Sale
$1,001 - $15,000